DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 45 filers reported holding DEPOMED INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $3,092,000 | +9.6% | 4,000,000 | 0.0% | 0.29% | -4.3% |
Q4 2018 | $2,822,000 | +532.7% | 4,000,000 | +566.7% | 0.30% | +1226.1% |
Q3 2017 | $446,000 | -36.6% | 600,000 | -25.0% | 0.02% | -37.8% |
Q2 2017 | $704,000 | -6.5% | 800,000 | 0.0% | 0.04% | -7.5% |
Q1 2017 | $753,000 | -18.0% | 800,000 | 0.0% | 0.04% | -9.1% |
Q4 2016 | $918,000 | -35.8% | 800,000 | -20.0% | 0.04% | -33.3% |
Q3 2016 | $1,429,000 | +18.0% | 1,000,000 | 0.0% | 0.07% | +17.9% |
Q2 2016 | $1,211,000 | -14.6% | 1,000,000 | -33.8% | 0.06% | -16.4% |
Q1 2016 | $1,418,000 | -17.7% | 1,510,000 | 0.0% | 0.07% | -17.3% |
Q4 2015 | $1,722,000 | -4.5% | 1,510,000 | 0.0% | 0.08% | -2.4% |
Q3 2015 | $1,804,000 | -19.1% | 1,510,000 | -13.2% | 0.08% | -11.7% |
Q2 2015 | $2,229,000 | -3.2% | 1,740,000 | 0.0% | 0.09% | -13.8% |
Q1 2015 | $2,303,000 | +21.7% | 1,740,000 | 0.0% | 0.11% | +41.6% |
Q4 2014 | $1,892,000 | +2.9% | 1,740,000 | 0.0% | 0.08% | +8.5% |
Q3 2014 | $1,838,000 | – | 1,740,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 5,500,000 | $4,633,000 | 2.75% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 27,019,000 | $22,776,000 | 0.90% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 12,500,000 | $10,563,000 | 0.80% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 51,016,000 | $42,853,000 | 0.76% |
UBS OCONNOR LLC | 41,000,000 | $34,203,000,000 | 0.61% |
Man Investments (CH) AG | 600,000 | $508,000 | 0.48% |
ADVENT CAPITAL MANAGEMENT /DE/ | 20,534,000 | $17,398,000 | 0.33% |
Senvest Management, LLC | 5,000,000 | $4,228,000 | 0.30% |
CQS Cayman LP | 4,706,000 | $4,036,000 | 0.26% |
CSS LLC/IL | 4,436,000 | $3,755,000 | 0.18% |